|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/127 | |
| A61K 31/4375 |
| (11) | Patento numeris | 2968146 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14764361.3 |
| Europos patento paraiškos padavimo data | 2014-03-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/029907 |
| Data | 2014-03-15 |
| (87) | Numeris | WO 2014/145187 |
| Data | 2014-09-18 |
| (30) | Numeris | Data | Šalis |
| 201361792850 P | 2013-03-15 | US |
| (72) |
KAN, Pei, TW
TSENG, Yun-Long, TW
OU, Han, Chun, TW
|
| (73) |
Taiwan Liposome Company, Ltd.,
2F 3 Yuanqu Street Nangang District, Taipei City 11503,
TW
TLC Biopharmaceuticals, Inc., 611 Gateway Blvd., Suite 830, South San Francisco CA 94080, US |
| (54) | CONTROLLED DRUG RELEASE LIPOSOME COMPOSITION |
| CONTROLLED DRUG RELEASE LIPOSOME COMPOSITION |